August 28, 2026
Published by Association for Multisite Research Corporations (AMRC)
In a recent AMRC interview, Paradigm Clinical Research CEO Kurt Mussina discusses why traditional measures such as enrollment, geographic reach, investigator counts and study experience tell only part of the story when evaluating clinical research site organizations.
The article explores the importance of looking beyond scale to understand how a site organization actually operates, including its organizational structure, governance, infrastructure and ability to execute consistently across locations. Mussina also discusses the need for a common industry vocabulary to more clearly distinguish among different site operating models.
The article covers:
- Why traditional site metrics provide an incomplete view of operational capability
- How differences in site operating models can affect execution, quality and scalability
- The need for clearer terminology and a common framework for understanding multisite research organizations
- How operating structure can give sponsors and CROs greater insight into execution reliability and consistency
- How strong operational support can reduce administrative burden on PIs and allow greater focus on medical oversight and patient care
Read the full article from AMRC:
Beyond the Numbers: Kurt Mussina on Rethinking How Clinical Research Sites Are Evaluated
About Paradigm Clinical Research
Paradigm Clinical Research is a clinical research site organization supporting phase I–IV programs across metabolic disease, dermatology, pulmonology, neurology, psychiatry, ophthalmology, and vaccines and infectious disease. Paradigm operates wholly owned clinical trial sites with centralized governance and infrastructure designed to minimize operational variability across sites, a common challenge in multi-site clinical trials.
In collaboration with more than 40 board-certified principal investigators, the company delivers expertly conducted clinical studies and access to diverse and specialty patient populations for sponsors and CRO partners. Additional information is available at www.paradigm-research.com.